PARD3 and prostate carcinoma: In prostate cancer, the dissociation of the Par3/aPKC/Kibra complex caused by the downregulation of Par3 activates the Hippo pathway by restoring the phosphorylation of Lats and then leads to the phosphorylation of Yap for a cytoplasmic arrest (73) (Figure 2).